By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Can-Fite BioPharma Ltd. 

Reinhold Cohn House
P.O.Box: 4060
Tel Aviv      Israel
Phone: 03-7109330 Fax: 03-5606405


Drug Discovery

Company News
Can-Fite BioPharma (CFBI) Reports Financial Results For Nine Months Ended September 30, 2015 11/30/2015 8:16:20 AM
Can-Fite BioPharma (CFBI) Announces Compelling Pre-Clinical Data On CF102 In The Treatment Of Non-Alcoholic Steatohepatitis (NASH) 11/23/2015 6:43:42 AM
Can-Fite BioPharma (CFBI) To Participate In BIO-Europe Partnering Conference On November 2-5, 2015 In Munich, Germany 10/26/2015 10:59:45 AM
Can-Fite BioPharma (CFBI) Release: New Study Demonstrates CF602 Mechanism Of Action To Improve Sexual Dysfunction 10/22/2015 9:22:25 AM
Can-Fite BioPharma (CFBI) Announces $4.8 Million Registered Direct Offering 10/13/2015 6:35:31 AM
European Medicines Agency Grants Orphan Designation To Can-Fite BioPharma (CFBI)'s CF102 In The Treatment Of Liver Cancer 10/12/2015 6:08:48 AM
Can-Fite BioPharma (CFBI) To Deliver 2 Presentations On Its Cancer Drug CF102 At The 20th World Congress On Advances In Oncology And 18th International Symposium On Molecular Medicine On October 8-10, 2015 In Athens 10/7/2015 6:43:19 AM
Can-Fite BioPharma (CFBI) To Present CF101 Psoriasis Data At Late Breaking Session Of The EADV Congress In Copenhagen On October 10, 2015 9/29/2015 10:39:52 AM
Can-Fite BioPharma (CFBI) Closes $9 Million Registered Direct Offering 9/25/2015 11:34:43 AM
Can-Fite BioPharma (CFBI) Announces $9 Million Registered Direct Offering 9/21/2015 11:24:45 AM